Stories
Granules India Expands Globally, Incorporates Subsidiary in Brazil
C
CNBC TV18•02-10-2026, 21:17
Granules India Expands Globally, Incorporates Subsidiary in Brazil
- •Granules India Ltd has established a wholly owned foreign subsidiary, Triton Farmaceutica Do Brasil Ltda, in Brazil.
- •The new entity will operate in the pharmaceuticals industry, focusing on manufacturing, promotion, sales, and distribution in Brazil.
- •Triton Farmaceutica Do Brasil Ltda is now a related party to Granules India, with no promoter interest.
- •The incorporation requires prior approval from the Reserve Bank of India under the automatic route.
- •Granules India reported a 60% year-on-year rise in net profit to ₹180 crore for the June quarter FY27, with revenue up 22%.
Key Questions Answered
Granules India incorporated a wholly owned foreign subsidiary named Triton Farmaceutica Do Brasil Ltda in Brazil to manufacture, promote, sell, and distribute pharmaceuticals and related products.
Granules India reported a 60% year-on-year rise in net profit to ₹180 crore for the June quarter of FY27, while revenue grew 22% to ₹1,476 crore and EBITDA increased by 37.4% to ₹339 crore.
Priyanka Chigurupati stated that moving large-scale generic drug production from India to the US would be difficult and costly, though Granules India is prepared to expand US manufacturing if required and expects the final tariff structure to be lower than initially announced.
